The global network of cancer projects - We support innovators who challenge the status quo and enable lifesaving solutions to reach their full potential.
Improve your investment deal-flow by joining our investor briefing session on June 2nd, where 4 fast-growing startups will pitch their solutions to investors in under 1 hour!๐ค๐
More information: https://t.co/4w5t8OFMmO
#dealflow#HealthTech#lifescienceinvestment
New collaboration between @ClabVentures and @life_sc_factory! What do we do together? Startup Academy is a online acceleration programme for health tech and oncology startups with workshops and face-to-face mentoring sessions with highly qualified professionals. STAY TUNED.
Check out our Programme outline for 2021 to see what we have planned for this year in our commitment to support innovators and accelerate solutions to beat cancer.
https://t.co/DHntX8Xzbw
Delighted to meet Sara Korchmaros from @cLABVentures [a #medtech accelerator focused on #Oncology] at #WebSummit 2020. See our full interview here ๐https://t.co/KGX7oWaar7 ๐บThanks so much team @websummit for the amazing #mingle feature!!
Last week we had the second session of our Global Mentorship Programme on resource management with Lilit Hovhannisyan who is an #investment manager at @GranatusVC
We discussed her career as a finance professional, her personal motivation and more #startup
https://t.co/iccy42NvVa
11 ONCOLOGY STARTUPS TO WATCH IN 2020๐
The 11 MedTech companies participating in cLAB Ventures Global Mentorship Programme have kicked off with great success.
https://t.co/0JDdM4PIcU
๐ ๐ผ๐ฟ๐ฒ ๐๐ต๐ฎ๐ป ๐ต๐ฌ ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ถ๐ฒ๐, ๐ผ๐ฟ๐ด๐ฎ๐ป๐ถ๐๐ฎ๐๐ถ๐ผ๐ป๐ ๐ฎ๐ป๐ฑ ๐ถ๐ป๐ฑ๐ถ๐๐ถ๐ฑ๐๐ฎ๐น๐ ๐ณ๐ฟ๐ผ๐บ ๐ผ๐๐ฒ๐ฟ ๐ฑ ๐ฐ๐ผ๐ป๐๐ถ๐ป๐ฒ๐ป๐๐ have already joined the Expara VirTech Global Accelerator๐ as ๐ฃ๐ฎ๐ฟ๐๐ป๐ฒ๐ฟ๐. Thank you very much for your supportโ๏ธ๐คฉ
It's #WorldCancerDay and we can't think of a better day to thank all of our partners who make cLAB Ventures a truly innovative and global network of #oncology#startups and research projects.
Are you an oncology startup or biotech investors? Join us
https://t.co/nUiiQca4Kq
The most lucrative area of focus at the moment is oncology for many pharma giants. Merck is not an exception. #oncology#venturecapital#startups#investment
https://t.co/Qtp2SzhG28
Sanofi agreed to buy the biotech startup Synthorx Inc. for $2.5 billion, and Merck to buy ArQule for almost $3 billion.
The deals underscore the growing popularity of investing in innovative therapies in the cancer field.
https://t.co/gL3PfBKk39
#oncology#Pharmaceutical
As life expectancy rises, cancer diagnoses are predicted to increase 60% by 2040, creating large new markets for pharmaceutical firms โ especially as patients become resistant to existing treatments. Via @finimize https://t.co/NNKARGLIVs
The prevalence of cancer may be growing, but itโs being beaten. Survival rates are up in the US. Earlier detection + improved treatment = countless lives saved. https://t.co/MAz0UckiWj #bnews
Many companies use traditional models based on in-house R&D teams and supporting universities and suppliers. These models are not as effective as others based on open innovation...
https://t.co/IOPbKHFKBp
This week weโre celebrating our quality improvement work at Velindre and showcasing some of the brilliant projects implemented by staff.๐
Weโre kicking off #VQiWeek with Dr Ricky Frazer and Steffanie Pothecary who set out to increase Oncology as a career of choice across Wales.
Bioscience Startup Founders: Expect Bumps In The Road From Academic To Entrepreneur -
The best strategy for any aspiring bioscience entrepreneur is to simply take chances.
https://t.co/kWs95gEYUI